CN110563698A - Novel protein cross-linking agent and preparation method thereof - Google Patents

Novel protein cross-linking agent and preparation method thereof Download PDF

Info

Publication number
CN110563698A
CN110563698A CN201910673959.4A CN201910673959A CN110563698A CN 110563698 A CN110563698 A CN 110563698A CN 201910673959 A CN201910673959 A CN 201910673959A CN 110563698 A CN110563698 A CN 110563698A
Authority
CN
China
Prior art keywords
novel protein
sulfo
preparing
formula
crosslinking agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910673959.4A
Other languages
Chinese (zh)
Inventor
聂承斌
李宏林
陆雪根
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Hao Fan Biological Ltd By Share Ltd
Original Assignee
Suzhou Hao Fan Biological Ltd By Share Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou Hao Fan Biological Ltd By Share Ltd filed Critical Suzhou Hao Fan Biological Ltd By Share Ltd
Priority to CN201910673959.4A priority Critical patent/CN110563698A/en
Publication of CN110563698A publication Critical patent/CN110563698A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

the invention discloses a preparation method of a novel protein cross-linking agent, which comprises the following steps; (a) adding Sulfo-NHS shown in the formula (I) into a first reaction solvent, and carrying out condensation reaction with 3- (2-pyridine dithio) propionic acid shown in the formula (II) under the action of a condensing agent and a catalyst to obtain Sulfo-SPDP shown in the formula (III). The invention takes Sulfo-NHS and 3- (2-pyridine dithio) propionic acid as raw materials, and the compound Sulfo-SPDP is obtained through condensation reaction, the synthetic route is short, the yield can reach 60 percent, the synthetic method has the characteristics of simple and convenient operation, easily controlled conditions, wide material source, high production efficiency and obvious production advantages.

Description

Novel protein cross-linking agent and preparation method thereof
Technical Field
The invention relates to the technical field of compound preparation, in particular to a novel protein cross-linking agent and a preparation method thereof.
background
N-hydroxysuccinimide-3- (2-pyridyl dithio) -propionate (SPDP) (IV) is a heterotype bifunctional protein cross-linking agent, wherein a 2-pyridyl dithio group in the structure can react with fatty thiol and can also perform exchange reaction with a thiol group in a protein structure so as to realize cross-linking with protein, an activated ester component at the other end can perform chemical reaction with amino groups and the like in chemical drugs, and finally, the bridge coupling of the protein and the chemical drugs is obtained, so that the drugs have a targeting effect and are key reagents of antibody coupling (ADC) drugs.
Because the reaction of protein participation is generally carried out in water or polar solvent, the water-soluble cross-linking agent can participate in the reaction better, thereby realizing the bridging coupling of the protein and the chemical drug, and the development of the water-soluble protein cross-linking agent has wide application prospect. The invention provides a synthetic method of a water-soluble cross-linking agent Sulfo-SPDP, wherein Sulfo-SPDP (III) is a protein cross-linking agent with good water solubility, and the related structural formula is shown as follows.
Disclosure of Invention
The present invention has been made to solve the above-mentioned problems occurring in the prior art, and an object of the present invention is to provide a simple and efficient method for synthesizing a novel protein crosslinking agent.
in order to achieve the purpose, the invention provides the following technical scheme: a novel protein crosslinking agent having the structure of formula (III):
a preparation method of a novel protein cross-linking agent comprises the following steps;
(a) Adding Sulfo-NHS shown in the formula (I) into a first reaction solvent, and carrying out condensation reaction with 3- (2-pyridine dithio) propionic acid shown in the formula (II) under the action of a condensing agent and a catalyst to obtain Sulfo-SPDP shown in the formula (III):
Preferably, in the step (a), the molar weight ratio of the Sulfo-NHS, the 3- (2-pyridyldithio) propionic acid, the condensing agent and the catalyst is 1:1 to 1.5:1 to 2:0.1 to 1, and the molar weight ratio is preferably 1:1.1:1.2: 0.1.
Preferably, in the step (a), the condensing agent is any one or more of EDCI, DCC, and DIC, and the condensing agent is preferably DIC.
Preferably, in step (a), the catalyst is any one or more of tetrabutylammonium chloride, benzyltriethylammonium chloride and tetrabutylammonium bromide, and the catalyst is preferably benzyltriethylammonium chloride.
Preferably, in the step (a), the condensation reaction temperature is 0-25 ℃, the condensation reaction time is 10-24 hours, the reaction temperature is preferably 25 ℃, and the reaction time is 17 hours.
preferably, in step (a), the first reaction solvent is: tetrahydrofuran, N-dimethylformamide and N, N-dimethylacetamide, and the first reaction solvent is preferably N, N-dimethylformamide.
preferably, in the step (a), after the condensation reaction is completed, the method may further comprise the following steps: evaporating the solvent, pulping and purifying, wherein the solvent used in pulping comprises one or more of ethyl acetate, acetone and methanol.
The invention provides a novel protein cross-linking agent and a preparation method thereof, and the novel protein cross-linking agent has the beneficial effects that:
1. The invention takes Sulfo-NHS and 3- (2-pyridine dithio) propionic acid as raw materials, and the compound Sulfo-SPDP is obtained through condensation reaction, the synthetic route is simple and short, and the yield can reach 60%;
2. The synthesis method has the characteristics of simple and convenient operation, easily controlled conditions, wide material sources, high production efficiency and obvious production advantages.
Detailed Description
The present invention will be described in further detail with reference to the following specific examples. The procedures, conditions, experimental methods and the like for carrying out the present invention are general knowledge and common general knowledge in the art except for the contents specifically mentioned below, and the present invention is not particularly limited.
Example 1
Dissolving 0.46g of Sulfo-NHS and 0.5g of 3- (2-pyridyldithio) propionic acid in 7mLN, N-dimethylformamide in a single-neck flask, stirring for a while, adding 0.35g of DIC, reacting at room temperature for 24 hours, detecting that the raw materials are completely reacted by TLC, evaporating to dryness of N, N-dimethylformamide, pulping with ethyl acetate once, and pulping with acetone twice to obtain 0.42g of Sulfo-SPDP (III), wherein the yield is 48%;
1H NMR(500MHz,DMSO-d6)δ8.51-8.49(m,1H),7.68-7.64(m,2H),7.15-7.12(m,1H),4.30-4.27(m,1H),3.33-3.25(m,2H),3.18–3.14(m,2H),3.10–3.07(m,2H)。
Example 2
Dissolving 0.46g of Sulfo-NHS, 0.5g of 3- (2-pyridyldithio) propionic acid and 0.05g of benzyltriethylammonium chloride in 7mL of N, N-dimethylformamide in a single-mouth bottle, stirring for a moment, adding 0.35g of DIC, reacting at room temperature for 17 hours, detecting the reaction completion of raw materials by TLC, evaporating N, N-dimethylformamide to dryness, pulping with ethyl acetate once, and pulping with acetone twice to obtain 0.53g of Sulfo-SPDP (III), wherein the yield is 60%;
1H NMR(500MHz,DMSO-d6)δ8.51-8.49(m,1H),7.68-7.64(m,2H),7.15-7.12(m,1H),4.30-4.27(m,1H),3.33-3.25(m,2H),3.18–3.14(m,2H),3.10–3.07(m,2H)。
Example 3
Dissolving 0.46g of Sulfo-NHS, 0.5g of 3- (2-pyridyldithio) propionic acid and 0.05g of benzyltriethylammonium chloride in 7mL of N, N-dimethylformamide in a single-mouth bottle, stirring for a moment, adding 0.52g of DCC, reacting at room temperature for 17 hours, detecting the reaction completion of raw materials by TLC, evaporating N, N-dimethylformamide to dryness, pulping with ethyl acetate once, and beating with acetone twice to obtain 0.31g of Sulfo-SPDP (III), wherein the yield is 35%;
1H NMR(500MHz,DMSO-d6)δ8.51-8.49(m,1H),7.68-7.64(m,2H),7.15-7.12(m,1H),4.30-4.27(m,1H),3.33-3.25(m,2H),3.18–3.14(m,2H),3.10–3.07(m,2H)。
In conclusion, the method for preparing the novel protein cross-linking agent has the advantages of short synthetic route, simple and convenient operation, low cost and high yield.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.

Claims (8)

1. A novel protein crosslinking agent characterized by: the structure is shown as the structural formula (III):
2. A method for preparing a novel protein cross-linking agent is characterized by comprising the following steps: comprises the following steps;
(a) Adding Sulfo-NHS shown in the formula (I) into a first reaction solvent, and carrying out condensation reaction with 3- (2-pyridine dithio) propionic acid shown in the formula (II) under the action of a condensing agent and a catalyst to obtain a compound shown in the formula (III)
Sulfo-SPDP, the reaction sequence is shown in scheme (1):
3. the method for preparing a novel protein crosslinking agent according to claim 2, wherein: in the step (a), the molar ratio of the Sulfo-NHS, the 3- (2-pyridyldithio) propionic acid, the condensing agent and the catalyst is 1: 1-1.5: 1-2: 0.1-1.
4. The method for preparing a novel protein crosslinking agent according to claim 2, wherein: in the step (a), the condensing agent is any one or more of EDCI, DCC and DIC.
5. The method for preparing a novel protein crosslinking agent according to claim 2, wherein: in the step (a), the catalyst is one or more of tetrabutylammonium chloride, benzyltriethylammonium chloride and tetrabutylammonium bromide.
6. the method for preparing a novel protein crosslinking agent according to claim 2, wherein: in the step (a), the condensation reaction temperature is 0-25 ℃, and the condensation reaction time is 10-24 hours.
7. the method for preparing a novel protein crosslinking agent according to claim 2, wherein: in step (a), the first reaction solvent is: any one or more of tetrahydrofuran, N-dimethylformamide and N, N-dimethylacetamide.
8. The method for preparing a novel protein crosslinking agent according to claim 2, wherein: in the step (a), after the condensation reaction is completed, the method may further include the steps of: evaporating the solvent, pulping and purifying, wherein the solvent used in pulping comprises one or more of ethyl acetate, acetone and methanol.
CN201910673959.4A 2019-07-25 2019-07-25 Novel protein cross-linking agent and preparation method thereof Pending CN110563698A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910673959.4A CN110563698A (en) 2019-07-25 2019-07-25 Novel protein cross-linking agent and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910673959.4A CN110563698A (en) 2019-07-25 2019-07-25 Novel protein cross-linking agent and preparation method thereof

Publications (1)

Publication Number Publication Date
CN110563698A true CN110563698A (en) 2019-12-13

Family

ID=68773485

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910673959.4A Pending CN110563698A (en) 2019-07-25 2019-07-25 Novel protein cross-linking agent and preparation method thereof

Country Status (1)

Country Link
CN (1) CN110563698A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111333664A (en) * 2020-03-27 2020-06-26 苏州昊帆生物股份有限公司 Biotin cross-linking agent, application and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101098703A (en) * 2004-11-05 2008-01-02 费城儿童医院 Biodegradable linkers for molecular therapies
US20090092664A1 (en) * 2007-10-08 2009-04-09 University Of Kentucky Research Foundation Polymer-metal chelator conjugates and uses thereof
US20130338342A1 (en) * 2011-03-01 2013-12-19 Chuo University Hemoglobin-albumin complex, and artificial plasma expander and artificial oxygen carrier containing the complex
CN104066451A (en) * 2011-07-19 2014-09-24 希默赛生物技术有限责任公司 Novel crosslinking reagents, macromolecules, therapeutic conjugates, and synthetic methods thereof
CN109824565A (en) * 2019-03-25 2019-05-31 华东理工大学 A kind of optical Response multifunctional chemical crosslinking agent and the preparation method and application thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101098703A (en) * 2004-11-05 2008-01-02 费城儿童医院 Biodegradable linkers for molecular therapies
US20090092664A1 (en) * 2007-10-08 2009-04-09 University Of Kentucky Research Foundation Polymer-metal chelator conjugates and uses thereof
US20130338342A1 (en) * 2011-03-01 2013-12-19 Chuo University Hemoglobin-albumin complex, and artificial plasma expander and artificial oxygen carrier containing the complex
CN104066451A (en) * 2011-07-19 2014-09-24 希默赛生物技术有限责任公司 Novel crosslinking reagents, macromolecules, therapeutic conjugates, and synthetic methods thereof
CN107043339A (en) * 2011-07-19 2017-08-15 希默赛生物技术有限责任公司 New cross-linking reagent, macromolecular, treatment conjugate and its synthetic method
CN109824565A (en) * 2019-03-25 2019-05-31 华东理工大学 A kind of optical Response multifunctional chemical crosslinking agent and the preparation method and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王文学: "异型双功能交联剂SPDP合成法的改进", 《第四军医大学学报》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111333664A (en) * 2020-03-27 2020-06-26 苏州昊帆生物股份有限公司 Biotin cross-linking agent, application and preparation method thereof

Similar Documents

Publication Publication Date Title
WO2018058816A1 (en) Method for manufacturing polyoxazoline chain extending agent
CN101372473B (en) Preparation of N-hydroxy diimide
CN112142963B (en) Biodegradable high molecular weight polyester synthesis method and application
CN111423580A (en) Shape memory resin based on biomass benzoxazine and preparation method and application thereof
CN110563698A (en) Novel protein cross-linking agent and preparation method thereof
CN106432706B (en) A kind of self-emulsification aqueous polyester emulsion and preparation method thereof
CN104961845B (en) A kind of mono alkenyl cyclodextrin function monomer and preparation method thereof
CN104987287B (en) A kind of preparation method of spherical Lysine m-benzoylhydratropate
CN111111552B (en) Malathion-based saccharide surfactant and preparation method and application thereof
CN107501134A (en) Asymmetric benzene sulfonic acid sodium salt Gemini surface active and preparation method thereof
CN110256658B (en) Multicolor fluorescent hyperbranched polyaminoester and preparation method thereof
CN110746349B (en) Preparation method of m-difluoroalkylphenoxypyridine compound
CN110183640A (en) Degradable polymer based on valerolactone derivative ring-opening polymerisation and preparation method thereof and purposes
JP2008308690A (en) Poly (ethylene glycol) functional derivative and method of producing the same
CN110981795B (en) Method for preparing 2-aminoacyl isonicotinic acid by using methyl 2-cyanoisonicotinate
CN105218511B (en) A kind of fatty aldehyde contracting glycerine Di-sodium Sulfo-succinate Mono Est-er and its preparation technology
EP0216162A2 (en) A method of preparing indoles or indole derivatives, coupled via position 4, 5, 6, or 7, the indoles or indole derivatives concerned, as well as the use thereof
CN108341770A (en) A kind of preparation method of Sorafenib compound
CN115215780B (en) Method for preparing heterobifunctional crosslinking agent SMCC by using N, N-disuccinimidyl carbonate
CN101220139B (en) Synthesis of terminal alkynyl different topological structured poly-caprolactone
CN110746597B (en) Ruthenium-based catalyst Ru-PPh2CO, preparation method and application
CN111574448B (en) Preparation method of phenyl tetrahydroisoquinoline
CN101735287A (en) Method for preparing 2, 3, 4, 6-tetraacylglucopyranose
JP3418693B2 (en) D-galactopyranosyl-gluconic acid derivatives of poly-ε-substituted-L-lysine
CN117466850A (en) Preparation method of 4-phenylethynyl phthalic anhydride

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20191213